ACTG trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ACTG achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Acacia Research Corporation (ACTG) has a Wall Street consensus price target of N/A, based on estimates from 7 covering analysts. The company has a market capitalization of $469M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ACTG trades at a trailing P/E of 22.1x. Analysts expect EPS to grow -131.5% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
IDCCInterDigital, Inc. | $7.6B | $296.04 | $450.00 | +52.0% | Buy | 41.1x | 16 |
VHCVirnetX Holding Corp | $52M | $12.53 | — | — | — | — | — |
XOMAXOMA Royalty Corp. | $525M | $41.89 | $44.50 | +6.2% | Buy | 53.3x | 10 |
QCOMQUALCOMM Incorporated | $238.3B | $226.11 | $191.05 | -15.5% | Hold | 21.1x | 69 |
FORMFormFactor, Inc. | $11.7B | $149.55 | $134.00 | -10.4% | Buy | 61.0x | 19 |
CEVACEVA, Inc. | $1.4B | $49.72 | $45.40 | -8.7% | Buy | 94.2x | 25 |
SIFYSify Technologies Limited | $1.1B | $15.20 | — | — | Buy | — | 1 |
IBMInternational Business Machines Corporation | $233.7B | $249.10 | $311.33 | +25.0% | Hold | 20.0x | 50 |
INTCIntel Corporation | $672.8B | $133.99 | $89.08 | -33.5% | Hold | 123.6x | 84 |
AAPLApple Inc. | $4.4T | $298.01 | $326.47 | +9.6% | Buy | 34.0x | 110 |
Quick answers to the most common questions about buying ACTG stock.
The consensus price target for ACTG is $N/A, close to the current price of $4.86 (N/A% implied move). Based on 7 analyst estimates, the stock appears fairly valued near current levels.
ACTG has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
ACTG's current price is $4.86 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for ACTG, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
ACTG is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ACTG stock forecast based on 7 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
ACTG appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ACTG analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.